Nov 2024 Ketamine: Considerations in Clinical Practice
Ketamine is a noncompetitive N-methyl-D-aspartate (NMDA) receptor antagonist. It is FDA approved for the induction and maintenance of anesthesia.1 When used...
Clinical Update
Jun 2024 New Nitazene Data – Ongoing Evaluation of an Emerging Threat
Gabapentin (Neurontin, Gralise, Horizant) was first approved by the US Food and Drug Administration (FDA) in 1993 for the treatment...
May 2024 Gabapentin: Highlights and Challenges
Gabapentin (Neurontin, Gralise, Horizant) was first approved by the US Food and Drug Administration (FDA) in 1993 for the treatment...
